Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGB-10188 in B-Cell Malignancies and Solid Tumors
NCT04282018Phase 2Completed
- Sponsor
- BeiGene
- Start
- Apr 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bgb-10188 in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), follicular lymphoma (FL), marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), sponsored by BeiGene. Started Apr 2020; status: completed.
02
Drugs
bgb-10188
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)follicular lymphoma (FL)marginal zone lymphoma (MZL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT04282018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282018.